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126Background: Low birth weight and prematurity and are known risks for mortality in congenital heart lesions. It
is not known whether risks of delayed intervention are offset by benefits of growth and maturation. We explored
this question.
Methods: All 1618 infants admitted to our institution within 30 days after birth for a congenital heart defect
since 2000 were analyzed. Birth details and admission progress notes were detailed on all. For infants requiring
cardiac interventions, clinical conference records and progress notes enabled their management to be classified
as either USUAL (normal timing and mode of intervention) or DELAYED (intentional delay for growth/matu-
ration). The survival implications of birth weight and prematurity were examined via parametric multiphase
methodology with bootstrap resampling. Subsequently, the impact of DELAYED management was sought in
propensity-adjusted and multivariable time-related models.
Results: Low birth weight is a strong, robust and independent predictor of death within the first year of life
(P<.0001; 99.6% bootstrap resamples). The relationship is nonlinear with an inflection point at approximately
2.0 kg, below which decrements in survival are increasingly pronounced. Prematurity is also associated with
poor outcome but less reliably so (P< .0001; 53% resamples); its variance appears partially mitigated by
colinearity with multiple factors including diagnosis and chromosomal aneuploidy. Of the 149 infants with birth
weight less than 2.0 kg (highest risk and most likely to receive delayed care in this cohort), care was USUAL in
34 and DELAYED in 46. The remaining children received comfort care only (27), were not considered for
intervention owing to severe noncardiac problems (12) or were routinely observed for nonurgent lesions (30).
Survival between the children weighing less than 2.0 kg and receiving USUAL or DELAYED care was identical
(78%  2% at 1 year; P ¼ .88), even when adjusted via propensity score (P ¼ 0.65) or multivariable analysis
(P ¼ 0.55). Major determinants of death in this very low-birth-weight population were antenatal diagnosis
(P ¼ .01), presence of congenital gastrointestinal defects (P ¼ .07), or lesion type (all higher risk: anomalous
pulmonary venous drainage, P ¼ .03; pulmonary atresia and intact septum, P ¼ .05; and truncus, P ¼ .01).
Conclusions: For very low-birth-weight neonates (<2.0 kg) with congenital heart defects, imposed delays in
intervention neither compromise nor improve survival. Other factors instead appear to account for survival dif-
ferences, including lesion type, associated noncardiac congenital defects, and antenatal diagnosis. (J Thorac
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Low birth weight and prematurity and are known risks for
mortality in surgery for congenital heart disease.1,2 For
these high-risk children, a clinical dilemma exists: whether
to pursue early (higher-risk) therapeutic intervention or else
impose a period of delay for growth and maturation before
(presumably lower-risk) intervention. It is not known
whether risks of delay are offset by benefits of growth and
maturation.
Because a prospective trial seems unlikely (or impossi-
ble), we investigated the influence of low birth weight or
prematurity on survival for neonates born with serious con-
genital heart lesions over the past decade at our institution.
Specifically, we aimed (1) to characterize the nature of lowery c January 2012
Hickey et al Congenital Heart Diseasebirth weight and prematurity as risk factors and then (2) to
explore the impact of imposed delays on survival for these
high-risk children.C
H
DMETHODS
Overview
In this investigation, we studied all neonates (aged<30 days) admitted
to our institution with structural congenital heart disease over the past 10
years (n ¼ 1618). Birth records were scrutinized for gestational age and
birth weight. Gestational age and birth weight were then explored as risk
factors for time-related death. For children who subsequently underwent
cardiac interventions, clinical conference records were explored for
decision-management strategies. Risk-adjusted survival was compared
between children in whom intervention was intentionally delayed (DE-
LAYED) versus those in whom usual active management strategies were
adopted (USUAL). The study was approved by our institutional research
ethics board; however, individual patient consent was not sought because
patients were not contacted directly.
Eligibility
The 1618 study patients were identified from reviewing our institutional
cardiology diagnostic database (Figure E1). Over the study period (January
2000–September 2010), 8497 children aged less than 3 months received
35,980 cardiology diagnostic codes during clinical consultations, investiga-
tions, or admissions. All 35,980 codes were individually reviewed to iden-
tify structural congenital heart disease (n ¼ 4171 children; eg, ventricular
septal defect or coarctation) as opposed to physiologic diagnoses (eg, hyper-
tension or atrial tachyarrhythmia). Isolated patent ductus arteriosus and be-
nign variants of normal (eg, isolated left superior vena cava to coronary
sinus) were not included. Individual case notes for all 4171 children were
scrutinized to identify only those 1618 whose cardiac diagnosis was partly
or wholly responsible for admission within 30 days after birth to any of our
cardiology, neonatal, or intensive care services (as a surrogate for the critical
nature of the problem). Consequently, our study cohort did not capture sub-
jects with cardiac lesions of amore benign naturemanaged as outpatients or
incidental diagnoses in neonates admitted for unrelated problems.
Data Abstraction
The 1618 study patients were subjected to a rigorous review of clinical
documents including antenatal records, delivery details, admission details,
diagnostic echocardiography reports, percutaneous and open surgical inter-
ventions, and clinical conference notes. Abstracted data were input into
a research database. Last contact dates and status were available on all
patients (mean, 3.4 years) to a maximum of 10.3 years.
Analytic Strategy
A: Impact of prematurity and birth weight on survival.
Our initial objective was to investigate the relative impact of prematurity
and birth weight on survival. These relationships were explored first by uni-
variate and then by multivariable (risk-adjusted) analyses (Results, section
A). The models thus produced allowed us to generate nomograms graphi-
cally depicting these nonlinear relationships to identify clinically important
‘‘thresholds.’’ In our analysis, birth weight less than 2.0 kg was identified as
a particularly important threshold for risk of death (Results, section A).
B: Classification of management strategy. Having deter-
mined birth weight less than 2.0 kg as a threshold below which survival
is particularly poor, the decision management for these 149 neonates was
then classified according the strategic intentions documented in clinical
conferences or progress notes. Our division holds weekly surgical confer-
ences in which all patients are discussed and decision management is docu-
mented. Management strategies were classified as follows: USUAL,
OBSERVE, DELAYED, NON-CV, and WITHDRAWN.The Journal of Thoracic and CaUSUAL. Early therapeutic intervention according to usual divisional
management paradigms in infants of normal weight. Therefore, the child’s
small birth weight has been disregarded, and management is entirely ac-
cording to ‘‘usual’’ care strategies adopted by our cardiovascular division
(eg, early scheduled repair of neonatal coarctation, early arterial switch
within 7 to 10 days for simple transposition of the great arteries, or Nor-
wood operation within 1 to 2 weeks for hypoplastic left heart syndrome).
OBSERVE. Early intervention not necessary. Therefore, observation/
expectant management is done in the first instance in accordance with typ-
ical divisional management paradigm. Imposed periods of delay for growth
are therefore not relevant, inasmuch as the diagnosis does not require early
intervention (eg, medical management of stable tetralogy of Fallot until
planned repair age of 5 to 6 months, observation of large ventricular septal
defect until repair at age 6 months, or observation of unobstructed total
anomalous pulmonary venous connection until repair at 6 weeks).
DELAYED. Intentional delay in early intervention to permit growth or
maturation. Therefore, low birth weight has specifically prompted a devia-
tion from usual divisional management paradigms (eg, 1.4-kg neonate with
coarctation maintained on prostaglandin with aim of repairing when>2.0
kg, or duct-dependent tetralogy of Fallot maintained with prostaglandin).
Children were included if a palliative approach (eg, shunt or band) was
pursued that was in contrast to usual divisional management paradigms,
specifically, to permit growth.
NON-CV. Higher priority noncardiovascular conditions dictating clini-
cal care; cardiovascular decision management lesser priority (eg, repair of
large ompalocoele delaying intervention for an interrupted arch).
WITHDRAWN. Active management withdrawn and comfort palliative
care instigated owing to unfavorable prognosis (eg, trisomy 18 with absent
corpus callosum, obstructive total anomalous pulmonary venous drainage,
and atrial isomerism).
C:Survival comparisonsbetweenUSUALandDELAYED
care in high-risk neonates. Time-related survival was compared be-
tween children whose management was either USUAL or DELAYED. Com-
parisons were made using univariate regression and then by risk-adjusted
techniques (multivariable regression and propensity adjustment).
Statistical Methods
Analysis was performed using parametric time-related techniques em-
ploying multiple hazard phases3,4 using techniques described in detail
elsewhere.5 All analyses were undertaken with SAS statistical software
(SAS Institute, Inc, Cary, NC) using freely available parametric
HAZARD macros (www.clevelandclinic.org/heartcenter/hazard). For
risk–hazard analyses, variables were tested in a univariate fashion and
subsequently multivariable (risk-adjusted) fashion using parametric auto-
mated forward stepwise regression. Variables were processed as previ-
ously described5 and were excluded if associated with fewer than 5
events (deaths) to avoid overdetermination. All continuous variables
were tested for transformations that improved model fit. Reliability of var-
iables reaching statistical significance (P<.05) was tested using bootstrap
resampling6 in which automated random training data sets are generated
(n ¼ 1000) against which the variables are tested. Inclusion of the variable
inmore than 50% of training data sets is interpreted as an indicator of
good reliability.1 For propensity adjustment, baseline patient-specific vari-
ables were entered into a logistic regression modeling the probability
(propensity) of management being USUAL or DELAYED. The logistic
model generated a cumulative probability (propensity score) for every
child. This propensity score was then inserted into subsequent multivari-
able regression models to account for subtle baseline differences between
the study groups.
Rate of growth was determined by using repeated-measures techniques.
Therefore, regression equations are adjusted for changes within individual
patients. For this repeated-measures analysis, generalized estimating equa-
tions were solved, adjusted for individual patients through autorecessiverdiovascular Surgery c Volume 143, Number 1 127
FIGURE 1. Survival from birth in the 1557 study children who were ac-
tivelymanaged. The hazard (risk) for deathwas predominantly early, within
the first year after birth. Thereafter, the persisting hazard for death was con-
stant and low (<<1% per year). Circles represent nonparametric estimates
at events (deaths), solid lines represent parametric determinants of contin-
uous point estimates, and dashed lines enclose 70% confidence intervals.
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Student’s t test (continuous variables) or Fisher’s exact test (frequencies).FIGURE 2. A, Histogram depicting the distribution of gestational ages in
all 1618 study patients. Term is considered 37 to 40 weeks; 1,320 infants
(82%) were born at term, and 294 (18%) were premature (only 4 infants
were born after term). Of the premature children, 197 were born at less
than 36 weeks, 49 at less than 32 weeks, and 13 at less than 28 weeks.
B, Nomogram illustrating the nonlinear relationship between gestational
age and survival in the 1557 actively managed children. This relationship
held true (and was more pronounced) if all 1618 children were analyzed
(including those 61 who received comfort care only).RESULTS
Of all 1618 neonates with structural congenital heart dis-
ease admitted within 30 days of birth to our institution since
2000, 238 (15%) died. A small proportion (n¼ 61; 4%) re-
ceived comfort care only, with no intended active manage-
ment of the congenital heart lesion, owing to associated
severe comorbidity. Time-related survival for the 1557 chil-
dren whowere actively managed for their condition is there-
fore shown in Figure 1. The overwhelming majority of
deaths occurred in the first year of life (Figure 1); for those
who survived to the age of 1 year, the hazard for death was
low and constant thereafter (<<1% per year).Section A
Relationship between gestational age and survival. The
distribution of gestational ages is depicted in Figure 2, A.
Gestational age strongly influenced subsequent risk of death
in a predictable way (P<.0001). The relationship was non-
linear (Figure 2, B). Gestational ages less than approxi-
mately 36 weeks were associated with disproportionately
worse survival, and for infants born at less than 32 weeks’
gestation this relationship was especially marked. Interest-
ingly, the impact of gestational age on survival was not lim-
ited to infants born prematurely. In a subanalysis of only the
1320 children born at term (37-42 weeks’ gestation), gesta-
tional age was still a significant determinant of survival
(P ¼ .0027): infants born at 42 weeks were predicted to
have 11% greater survival at 1 year versus those born at
37 weeks of gestation.
Relationship between birth weight and survival. The
distribution of birth weights is depicted in Figure 3, A.128 The Journal of Thoracic and Cardiovascular SurgLow birth weight—particularly below the normal range of
3.0 to 4.5 kg—strongly compromised survival
(P < .0001). The relationship was markedly nonlinear,
and birth weight less than 2.0 kg was particularly associated
with large decrements in survival (Figure 3, B). For infants
weighing less than 1.0 kg, fewer than half are predicted to
survive to 1 year; between 1 and 1.5 kg, survival is approx-
imately 60%; between 1.5 and 2.0 kg, survival is approxi-
mately 75%; and within the normal range of birth
weights, late survival is approximately 90% (Figure 3, B).
Therefore, for larger neonates, the survival differences re-
lated to birth weight were far less marked. Interestingly,
however, in a subanalysis of only the 928 infants born
within the normal weight range (3.0-4.5 kg), birth weight
was still a significant determinant of survival (P ¼ .02).
Relative importance of gestational age and birth weight.
When tested together, birth weight consistently predomi-
nated as the more reliable and dominant independent riskery c January 2012
FIGURE 3. A, Histogram depicting the distribution of weights for all
1618 study patients. Normal birth weight is generally considered to be
3.0 to 4.5 kg; 928 (57%) infants were born with normal birth weight.
Among the 652 born under 3.0 kg: 301 weighed less than 2.5 kg (low birth
weight), 149 weighed less than 2.0 kg, 61 weighed less than 1.5 kg (very
low birth weight), and 16 weighed less than 1.0 kg (extremely low birth
weight). B, Nomogram illustrating the nonlinear relationship between birth
weight and survival in the 1557 actively managed children. This relation-
ship held true (and was more pronounced) if all 1618 children were
analyzed (including those 61 who received comfort care only).
TABLE 1. Risk factors for death in all 1557 of the 1618 study children
who were actively managed (therefore excluding the 61 children who
received comfort care only)
PE P value Reliability (%)
Early risk factors
Atrioventricular septal defect 1.16 <.0001 98
Total anomalous PV connection 1.35 <.0001 98
Pulmonary atresia, IVS 1.19 .0002 84
Syndromic 1.02 .0007 78
Cardiac arrest at time of diagnosis 2.35 <.0001 78
Antenatal diagnosis 0.50 .0024 74
Birth weight (kg) 0.49 <.0001 73
LV hypoplasia 1.63 <.0001 65
Interrupted aortic arch 1.18 .0097 59
Apgar score at 1 minute 0.15 <.0001 51
Gestational age — .57 —
Late risk factors
Congenital CNS defect 3.11 <.0001 50
Gestational age was not a significant independent risk factor; when forced into the
model, its level of significancewas .57. The only risk factor with acceptable reliability
associated with increased risk of late phase death was presence of a congenital CNS
malformation. Similar analysis of all 1618 study children (including those 61 who
received comfort care only) revealed precisely the same risk factors listed, with the
addition of: presence of trisomy 13 (PE, 2.92; P<.0001), presence of trisomy 18
(PE, 2.14; P<.0001), and presence of Turner syndrome (PE, 1.72; P ¼ .018). PE,
Parameter estimate; PV, Pulmonary vein; IVS, intact ventricular septum; LV, left
ventricular; CNS, central nervous system.
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53%). Furthermore, in larger multivariable models incor-
porating all available baseline patient-specific variables
(diagnosis, genetic/chromosomal defects, and coexisting
noncardiac morbidity), gestational age was replaced in the
model by a range of colinear variables (Table 1). Therefore,
much of the impact (variance) of low gestational age on out-
come is attributable to these other risks. By contrast, low
birth weight remained a strong and reliable independent
risk factor for death (P<.0001, 99% bootstrap reliability);
particularly so for birth weight less than 2.0 kg.Section B
The 149 children weighing less than 2.0 kg were classi-
fied according to the management strategy pursued
(USUAL ¼ 34; DELAYED ¼ 46; OBSERVE ¼ 30;The Journal of Thoracic and CaNON-CV ¼ 12; WITHDRAWN ¼ 27). Characteristics of
the 80 neonates whose management was either USUAL
(n ¼ 34) or DELAYED (n ¼ 46) are given in Table 2.
Although statistically significant differences between the
groups are few, certain trends are apparent. In children man-
aged according to USUAL strategies, there appears to be
a higher prevalence of left-sided lesions, fewer associated
congenital defects, and fewer baseline morbidities. In con-
trast, in infants in whom a DELAYED strategy was pursued,
there was a higher frequency of right-sided lesions, associ-
ated congenital lesions, and baseline morbidities.Section C
The univariate (unadjusted) difference in survival was
not different between neonates managed according to
USUAL decision strategies versus those whose intervention
was DELAYED (P ¼ .88) (Figure 4, A). Multivariable risk
adjustment with baseline patient-specific variables revealed
no significant impact of a USUAL versus DELAYED strat-
egy (P ¼ .54). Finally, adjustment using patient-specific
variables and propensity score revealed a tendency for
slightly worse survival with a DELAYED strategy; how-
ever, this trend did not approach significance (P ¼ .65)
(Figure 4, B). Instead, important determinants of death in
this population of actively managed neonates born weigh-
ing less than 2.0 kg included antenatal diagnosis (P ¼ .01,
50% reliability) or presence of total anomalous pulmonary
venous connection (P ¼ .003, 50%), pulmonary atresiardiovascular Surgery c Volume 143, Number 1 129
TABLE 2. Characteristics of the 80 infants with birth weight<2 kg
who were actively managed according to either USUAL (n ¼ 34) or
DELAYED (n ¼ 46) clinical paradigms
USUAL DELAYED P value
No. 34 46 —
Dead 8 11 .97
Birth weight 1.66  0.06 1.44  0.05 .01
Gestational age 32.8 32.4 .62
Antenatal diagnosis 7 13 .60
Length of imposed delay — 8.0 (1 - 32) —
Diagnosis
Isolated coarctation 7 4 .19
CoarctationþVSD 3 1 .31
Diffuse LVOTO 3 0 .07
LV hypoplasia 3 1 .31
Isolated aortic stenosis 2 0 .18
Isolated AVSD 1 2 .71
AVSD 2 5 .69
Simple TGA 1 2 .75
TGAþVSD 0 0 —
TGAþVSDþPS 1 2 .75
Truncus arteriosus 2 4 .64
TAPVC 1 4 .39
DORV 0 6 .04
Tetralogy of Fallot (PS) 1 4 .39
Tetralogy of Fallot (PA) 2 4 .64
Pulmonary atresia, IVS 3 4 .98
RV hypoplasia 1 4 .39
Acquired baseline comorbidity
Neurologic 5 12 .28
Respiratory 8 14 .61
Gastrointestinal 2 10 .06
Genitourinary 0 2 .51
Cardiorespiratory arrest 1 0 .43
Sepsis 4 9 .54
Any associated morbidity 13 27 .11
Associated congenital defects
Neurologic 0 3 .26
Respiratory 0 1 .39
Gastrointestinal 0 6 .04
Genitourinary 3 10 .14
Dysmorphic 7 7 .56
Syndromic 0 6 .04
Known gene/Ch defect 4 10 .37
Any associated defect 4 19 .006
VSD, Ventricular septal defect; LVOTO, left ventricular outflow tract obstruction; LV,
left ventricular; AVSD, atrioventricular septal defect; TGA, transposition of the great
arteries; PS, pulmonary stenosis; PA, pulmonary atresia; IVS, intact ventricular
septum; Ch, chromosomal.
FIGURE 4. A, Univariate (unadjusted) comparison of survival between
children managed according to USUAL (n¼ 34) decision strategies versus
DELAYED (n ¼ 46). Survival in all 80 children was modeled parametri-
cally and stratified according to decision strategy. Survival was identical
(P¼ .88). B, Propensity-adjusted comparison of survival between children
managed according to USUAL decision strategies versus DELAYED. The
survival model for all 80 children was subjected to multivariable regression
analysis including baseline patient-specific variables and a propensity
score. Survival differences were not significant (P ¼ .65). Solid lines
represent parametric determinants of continuous point estimates. Dashed
lines enclose 70% confidence intervals.
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Dwith intact ventricular septum (P ¼ .005, 64%), or truncus
arteriosus (P ¼ .03, 79%).
Imposed delay. In the 46 children who had DELAYED
management, the mean length of time until delayed inter-
vention or death was 8.5 weeks (range, 1-32 weeks;
Figure 5, A). During the growth period, 18 (38%) patients
sustained important new clinical complications (Table 3).
Six (13%) children died while waiting for their delayed130 The Journal of Thoracic and Cardiovascular Surgintervention (Table 4). Four of these 6 had cyanotic lesions,
3 of whom were supported with long-term prostaglandins.
Three of these 4 had fatal cardiorespiratory arrests while re-
ceiving prostaglandin support and the fourth had a massive
thromboembolic stroke complicated by intractable seizures.
The remaining 2 deaths resulted from multiorgan failure
and an insidious realization that long-term prognosis was
futile; active care was withdrawn. There was no discernible
pattern regarding the duration that these 6 children waited
before dying (P ¼ .87). Although numbers were small,
logistic risk factors for death while waiting included a diag-
nosis of pulmonary atresia with intact ventricular septum
(P ¼ .02; parameter estimate,þ3.2), presence of syndromic
features (P ¼ .01; parameter estimate, þ3.4), and sepsis
(P ¼ .03; parameter estimate, 2.6).ery c January 2012
FIGURE 5. A, Histogram depicting the distributions of the lengths of
delay experienced by the 46 infants in whom a DELAYED strategy was
pursued. The timing of the 6 deaths that occurred are depicted by the red
symbol. B, Time-related rate of growth for the 46 individual patients in
the DELAYED group. These individual growth rates were subsequently
modeled collectively as a repeated-measures generalized estimating equa-
tion to explore the growth rate further. The mean growth rate was approx-
imately 95 g per week (95% confidence interval, 72-117 g; P<.0001).
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uration, the mean rate of growth was approximately 95 g per
week (95% confidence interval, 72-117 g; P < .0001;
Figure 5, B). Trends were sought to identify lesions associ-
ated with faster or slower growth rates, inasmuch as rate of
growth would have important clinical implications for the
cumulative risk imposed by a DELAYED strategy. Interest-
ingly, several lesions (tetralogy of Fallot, atrioventrciular
canal defects, and total anomalous pulmonary venous con-
nection) were associated with faster than average growth
rates (Table 5). By contrast, truncus arteriosus, aortic coarc-
tation, and pulmonary atresia with intact ventricular septum
were all associated with slower than average growth rates.
During the period of early recovery after intervention, the
prevalence of important clinical complications was similar
in both patient groups (Table 3). Importantly, the incidence
of cerebral complications occurring in children who under-
went USUAL intervention was not significantly elevated; of
the 3 cerebral bleeds that did occur in this group, 2 occurredThe Journal of Thoracic and Caon extracorporeal membrane oxygenation support. Among
children managed with a DELAYED strategy, several chil-
dren who experienced complications during the period of
delay also experienced complications after intervention.
Therefore, the proportion of children free from any new
important complication occurring after the time of cardiac
decision strategizing was 68% (23/34) and 28% (13/46)
for the USUAL and DELAYED groups, respectively
(P< .001). Consequently, the overall acquired burden of
complications was greater for the DELAYED group than
the USUAL group, although overall survival was not
different.
DISCUSSION
In our experience, high-risk neonates born weighing less
than 2.0 kg who received intentional delays in treatment to
promote growth and maturation had survival comparable
with that of similar neonates who received timely treatment
according to usual decision-management strategies. Infants
who received a delayed approach tended to have greater
baseline morbidity and associated noncardiac defects. The
mortality burden of these problems during the period of
growth did not appear to outweigh the intuitively elevated
risk of intervening early on low-birth-weight infants.
Strategizing for premature or low-birth-weight neonates
with congenital heart disease has long been a contentious
and unresolved issue; our experience does not lead us to
strongly recommend either an early interventional or de-
layed interventional approach over the other, although the
overall burden of complications appears to be significantly
greater in children managed with a delayed strategy.
It was of interest to us that low birth weight was consis-
tently a stronger determinant of poor outcome than prema-
turity per se. Our regression explorations imply that the
clinical impact of prematurity is largely represented by
other factors with strong colinear associations: certain unfa-
vorable diagnoses, syndromes, and clinical status. The im-
plication is therefore that a premature infant (with birth
weight>2.0 kg) in reasonable clinical condition may not
be at particularly elevated risk compared with a similar-
sized term child. In contrast, low birth weight appears to
confer high early surgical risk over and above other markers
of poor prognosis. Specific reasons for and the nature of this
risk are not well understood but may relate to technical
factors as well as nutrition,7 immunologic fitness,8 fluid
balance, and cardiovascular physiology. Low birth (or oper-
ative) weight has consistently been noted to be a risk factor
in other large lesion- or procedure-specific analyses of
surgery in neonates with congenital heart disease.5,9,10
Irrespective of low weight as an independent statistical
risk, whether its effect is completely mitigated in the
clinical world by weight gain is not certain. However, it is
this logic that forms the basis of a delayed therapeutic
strategy.rdiovascular Surgery c Volume 143, Number 1 131
TABLE 3. New important clinical complications sustained after the time of cardiac decision strategizing in children treated by USUAL and
DELAYED strategies
Important clinical complications
Before intervention (after decision strategizing) After intervention
USUAL DELAYED USUAL DELAYED
Patients having complications 0 18 11* 23*
Total complications (by system) — 33 18* 30*
Death — 6 8y 5y
Cardiac arrest/shock — 7 3 2
Pneumonia/ventilator-dependent — 7 1 4
Gastrointestinal — 5 3 5
Renal — 2 0 1
Cerebral — 2 3 (ECMO ¼ 2) 2
Thrombosis/hematologic — 4 3 6
Systemic sepsis — 7 3 9
ECMO, Extracorporeal membrane oxygenation. *Not statistically significant between groups. yTotal postoperative deaths (early and late).
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DSix children died during an intended period of growth: 4
directly attributable to the cardiovascular lesion and 2
attributable to escalating multisystem comorbidity. It is dif-
ficult or impossible to judge retrospectively whether early
cardiac repair would have been feasible in these latter 2
infants. However, it is of interest that 4 deaths occurred in
cyanotic right-sided lesions, 3 in the presence of long-
term prostaglandin therapy. A message penetrating through
our regression analyses may be that despite gaining weight
fairly rapidly, infants with right-sided cyanotic lesions are
in a more precarious condition during the growth period
and might therefore benefit instead from early therapeutic
approaches. By contrast, left-sided and mixing lesions (co-
arctations, total anomalous pulmonary venous connection,
truncus arteriosus, and transposition of the great arteries)
may be ‘‘safer’’ during the growth period and therefore
more suitable for a delayed approach.
The incidence of complications sustained during the pe-
riod of growth was high (38%) and affected all (frequently
multiple) bodily systems. To contextualize this, it would
be interesting to know the incidence and spectrum of com-
plications occurring in low-birth-weight newborns without
congenital heart disease in an intensive care environment.
Many of the complications (necrotizing enterocolitis,
stroke, pneumonia, and thrombosis) are endemic to neonatal
intensive care environments.11-14 Minimizing the incidenceTABLE 4. Summary of the 6 children who died during a DELAYED strat
Case
Birth
weight (kg)
Time to
death (wk) Diagnosis
Therapy
whilegrowin
1 1.5 1.5 Hemitruncus Supportive
2 0.9 3 TOF PGE1
3 1.7 11 TOF Supportive
4 1.3 1.5 PAIVS PGE1
5 1.4 2 PAIVS PGE1
6 1.1 14 Scimitar, VSD Supportive
TOF, Tetralogy of Fallot; PAIVS, pulmonary atresia with intact ventricular septum; VSD,
132 The Journal of Thoracic and Cardiovascular Surgand severity of noncardiac morbidities should clearly be the
goal of any strategy of imposed therapeutic delay for growth
purposes. During delay for growth, weight gain should be
closely scrutinized. In our experience, the mean rate of
growth was 95 g per week, although this ranged widely:
some lesions demonstrated almost twice this growth rate,
whereas others were associated with less than half this rate
of growth. Intuitively, it seems sensible that a poor rate of
growth should prompt reevaluation of the clinical decision
to pursue a delayed strategy.
When considering the risk–hazard equation for very
small neonates, it is important to recognize that if the in-
creased operative risk of early intervention in low-birth-
weight neonates is mitigated, then imposed delays become
superfluous. Impressive results have been reported for re-
pairs for congenital heart defects on progressively smaller
infants including those weighing less than 2.5 kg,15,16 less
than 2.0 kg,17 less than 1.5 kg,18 and even as low as 0.7
kg.16 If noncardiovascular complications of prematurity
and low birth weight remain largely unresolved, it is likely
that, over time, the risk–hazard equation will gradually
swing in favor of progressively earlier intervention.
Finally, it is noteworthy, and academically problematic,
that particularly small infants presenting as a decision-
management dilemma are relatively infrequent. In our qua-
ternary institution with a broad referral base and annualegy, before definitive cardiac repair
g
Complications
while growing Mode of death
Intra-ventricular hemorrhage,
NEC, pneumonia
Withdrawn
Cerebral infarct, NEC Status epilepticus
Systemic sepsis, pneumonia Cardiorespiratory arrest
Apnea, desaturations Cardiac arrest
– Cardiorespiratory arrest
Pneumonia, tracheomalacia,
multiple congenital co-morbidities
Withdrawn
ventricular septal defect; PGE1, prostaglandin E1; NEC, necrotizing enterocolitis.
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TABLE 5. Summary of trends in the rate of growth for the 46 children
who underwent a DELAYED strategy
Tendency for birth weight Rate of growth
AVSD — Increase growth rate
(150%; P ¼ .045)
Tetralogy (PS/PA) — Increased growth rate
(140%; P ¼ .033)
TAPVC Trend toward smaller at birth
(300 g; P ¼ .07)
Increased growth rate
(150%); P ¼ .024)
Truncus arteriosus — Reduced growth rate
(50%; P ¼ .034)
Coarctation Trend toward bigger at birth
(300 g, P ¼ .03)
Reduced growth rate
(50%; P<.0001)
Pulmonary
atresia, IVS
— Slightly reduced rate
(70%; P.022)
Time-related rate of growth was explored using parametric generalized estimating
equations (adjusted for repeated measures). For the group as a whole, the mean start-
ing weight was 1.51 kg, and the average growth rate was 95 g per week. All diagnostic
categories and comorbidities were individually explored, and a summary of signifi-
cant trends is presented here. Magnitude of growth rates is expressed as a percentage
above or below the mean of 95 g per week and is derived from the parameter estimates
of the regression equations. AVSD, Atrioventricular septal defect; PS, pulmonary
stenosis; PA, pulmonary atresia; TAPVC, total anomalous pulmonary venous connec-
tion; IVS, intact ventricular septum.
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Dsurgical case volume exceeding 600, we identified only 80
such children in over a decade. Prospective investigations
into timing of intervention, although appealing, are therefore
impractical and unlikely. Instead, we must rely on
retrospective appraisal of our experiences. Similar retrospec-
tive approaches have been useful in the risk–hazard quantifi-
cation of staged versus primary repair of particular congenital
lesions (tetralogy of Fallot,19 pulmonary atresia with ventric-
ular septal defect and collaterals,20 and others21). However,
exploring strategic options in low-birth-weight children is
further hampered by their heterogeneity of diagnoses and
comorbidities. The low-birth-weight infants in our series
had a high incidence of congenital noncardiac defects,
syndromes, and acquired comorbidities such that statistical
adjustment can become difficult. We acknowledge the prob-
lems of patient diagnostic and clinical heterogeneity in our
analysis. It is for these reasons that we explored impact of de-
layed interventionusing several unadjustedandadjusted tech-
niques. Nevertheless, multivariable and propensity score
methodology can only make crude adjustments, particularly
if differences between groups are real and pronounced.
Although reassuring that outcome differences were not
observed irrespective of analytic approach, the subtle differ-
ences in diagnosis and comorbidity are likely of real clinical
importance for decision strategizing. The comorbidities in
some of the DELAYED children may have (unbeknown to
the retrospective researcher) prevented early intervention
and therefore have dictated a delayed approach; it is impossi-
ble to fully account for this.
In summary, low birth weight of less than 2.0 kg is
a strong, reliable, and independent predictor of poorThe Journal of Thoracic and Caoutcome for neonates born with congenital heart lesions.
Prematurity is a less important risk factor for death. For
high-risk low-birth-weight children, a clinical dilemma
exists: whether to pursue early (higher-risk) therapeutic in-
tervention or otherwise impose a period of delay for growth
and maturation before (presumably lower-risk) interven-
tion. In the past decade of our experience, imposed delays
were associated with nonfatal complications in approxi-
mately one third and death during the growth period in
13%. However, when comparing neonates with DELAYED
intervention versus USUAL early intervention, late survival
was comparable in both unadjusted and adjusted analyses.
Strategizing for premature or low-birth-weight neonates
with congenital heart disease has long been a contentious
and unresolved issue; our experience does not lead us to
strongly recommend either an early interventional or
delayed interventional approach over the other. Finally, al-
though overall survival for children managed via a delayed
strategywas not compromised, it is noteworthy that the total
complication burden experience by these children was sig-
nificantly greater.References
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Dr Scott M. Bradley (Charleston, SC). That was an excellent
presentation on a topic that is clearly a challenge to everyone in
the room. I thought that the information on the relative importance
of low birth weight versus prematurity was particularly interesting,
as was the growth velocity that can be expected in these low-birth-
weight babies. I do have a couple of questions about the ways in
which you have chosen to analyze your data.
The first question has to do with the 2 groups, which you call
‘‘early’’ and ‘‘delayed.’’ This differentiation was based on your ret-
rospective assessment of the goal of the management team at the
time that the patient presented. I commend you for going through
all of those charts and figuring that out. Nonetheless, some of the
patients in the delayed group underwent intervention within the
first 1 to 2 weeks of life, which would not be considered very
delayed and certainly not long enough to expect much growth.
Do you have any information for us on the ages at intervention
in the early group and whether there was overlap with what you
call the delayed group?
Dr Hickey. Thank you very much, Dr Bradley, for your
questions.
In terms of the categorization of patients, it is very difficult ret-
rospectively and it would be great to do a prospective study, but
that is simply impractical or impossible.
Rather than opt for procedure-based categories, for example,
palliation or repair, wewanted to categorize in terms of completely
deviating from the strategy. As best as I can, I think I have done
that.
In terms of the ages of the 2 groups, patients in the early group
were generally all intervened on the next available appropriate
clinical slot in the neonatal period after presenting, so within the
first 2 to 3 weeks after birth, whereas the mean age at intervention
for the delayed group was on average about 8 weeks later. Of
course, we had a number of deaths even within 1 to 2 weeks of
being delayed.
Dr Bradley. It appears that if the early group was intervened on
within the first 2 to 3 weeks after birth, there was significant over-
lap between the early and the delayed groups. That would probably
be good information to put in the article.
Would it have been more clear-cut to simply analyze the pa-
tients on the basis of their age at intervention as either a continuous
or a categorical variable, rather than trying to look back and134 The Journal of Thoracic and Cardiovascular Surgdetermine the intentions of the team at the time, which was up
to 10 years ago?
Dr Hickey. Certainly you can look at age at intervention, and
we have done so in several other series. We know age at interven-
tion is a very important variable. We specifically wanted to go back
to the decision-making algorithm from the outset and make a deci-
sion-making analysis rather than just a risk-hazard-based analysis
in retrospect.
Dr Bradley. I want to ask about a topic that you mentioned-the
type of interventions in the 2 groups. Many of these patients were
candidates for more than 1 intervention, for example, in tetralogy
of Fallot, complete repair versus palliation with a shunt, in hypo-
plastic left heart syndrome, Norwood versus hybrid procedure.
I assume that some of your patients underwent catheterization in-
terventions, for example, balloon septostomy in patients with
transposition and balloon aortic valvotomy in patients with aortic
stenosis. Other catheterization interventions, while not routine,
could be considered in selected patients, for example, stenting
the outflow tract or the ductus in tetralogy or pulmonary atresia.
Do you have any analysis of the breakdown of the types of inter-
vention in your 2 groups: complete repair versus palliation versus
catheterization laboratory?
Dr Hickey. It was our hope and intention from the outset that
we might end up with some homogeneous patient groups, either
in terms of diagnosis or in terms of interventional strategy, that
we could then compare. It was very clear from the outset, though,
that that was not going to be the case. This is actually quite an un-
common problem if you consider 80 patients over 10 years. We
have a catchment area of about 13 million at Toronto. This is ac-
tually quite an unusual dilemma, although it is one we are all
very familiar with. That is why we have such a heterogeneous
bunch. Therefore, it is very difficult to compare one specific inter-
ventional strategy versus another. We have not been able to do that.
In terms of the range of options for each child, that exists for
a normal-birth-weight child. Even for a child of normal birth
weight with tetralogy or truncus or whatever, there can be different
management strategies. We were only interested if we completely
deviated and did something different because of the very low birth
weight.
Dr Bradley. Fair enough. I think it would be useful to include
some information on whether you are talking about complete re-
pairs or palliation, especially in the early group. Although you
did factor patient diagnosis into your risk-adjustment analyses,
I would think you could enter complete repair versus palliation
into that analysis as well.
One final question: You have given us some valuable informa-
tion on the growth velocity that we can actually expect in these
low-birth-weight patients if we do decide to take a wait-and-feed
approach. Growth is generally more effective on enteral feeding
than on total parenteral nutrition. However, many practitioners
are reluctant to enterally feed a premature, low-birth-weight
baby, especially if the infant is receiving a prostaglandin infusion.
Can you tell us how the babies in your delayed group were ap-
proached in terms of feeding to achieve growth, from your review
of charts, or what your approach would be now, particularly in
a baby who is receiving a prostaglandin infusion?
Dr Hickey. Unfortunately, I cannot elaborate much on that in-
formation because we did not have those data. Nor am I, by anyery c January 2012
Hickey et al Congenital Heart Disease
C
H
Dstretch of the imagination, an expert on nutrition in these small in-
fants. Nevertheless, in our intensive care unit we aggressively try
to enterally feed all our infants unless there is a strong reason to
do otherwise. Obviously, we use fortified feeds with dietician
advice and all that sort of thing.
In terms of the difference between the growth rates, I was most
struck by the difference, especially the infants with coarctation,
which seemed to grow at a very high level of statistical significance
at a very low rate. That to us suggests that of all the groups, patients
with coarctation are maybe the ones on whom we should operate
early. Indeed, that iswhatwedonow routinely, down to1.4 to 1.5kg.
I have just one final comment about your previous comments
about palliation: At Sick Kids we have a very high threshold for
palliative strategies. In the mid-1990s we switched, for example,
from using any shunts for patients with tetralogy; it is rare, in
fact, that we use bands or shunts in children now. Indeed, in this
series they were very infrequent occurrences.
The data on long-term prostaglandin therapy, especially, is
encouraging us to now explore other catheter-based approaches
that can be used instead of long-term prostaglandin, especially
subxiphoid approaches for tiny infants.
Dr Bradley. Fair enough. I think it is a very nice study. It is
a relatively large group of patients with these issues. If you could
provide some of this additional information in the article, it would
be of interest to the readers.
Dr V. Mohan Reddy (Stanford, Calif). Dr Hickey, I would like
to ask you a few questions. I know you looked at a lot of risk
factors, but did you look at patients who were dependent for a pro-
longed period for mechanical ventilation or prostaglandins versus
patients who are not dependent?
Dr Hickey. As subgroups, no, but they were both included as
risk factors. We had acquired respiratory morbidity as a risk factor
from the outset as baseline.
Dr Reddy. From the data, I could see that patients whose treat-
ment was delayed had a significantly higher incidence of compli-
cations and there was also some mortality.
Dr Hickey. That is true.
Dr Reddy. But overall, there was no difference. What do you
think accounted for the mortality in the early group to equalize it?
Dr Hickey. Intuitively, the assumption is that intervening in
very small children is of elevated risk. We assume that the greater
morbidity and mortality burden is in some way outweighed by the
risk of intervening on these very small children.
Equally, we fully acknowledge that there are important differ-
ences within the patient groups, which is why we have tried to
look at it in multiple different ways; but we still are not seeing
an important difference between the 2 strategies.
Dr Reddy. Most likely, it could be technical. As with all tech-
nical operations, we gradually get better when we do the operation
over time. I can assure you that even though the patient’s weight
increases from 1.5 kg to 2 kg or 2.2 kg, the heart is not going to
be much bigger than 10 mg or 20 mg. Thus, I do not think it tech-
nically makes a huge difference. I think it is more in the mind than
in actually doing the operation.
Dr Hickey. In terms of the risk of actually performing the op-
eration, I agree, the technical aspects are very valid. Furthermore,
certainly most here will know that your group at Stanford has man-
aged to mitigate some of these issues, perhaps because of yourThe Journal of Thoracic and Caexperience with operating on fetal animals. You are much more at-
tuned to operate on the infant weighing 1.1 to 1.2 kg. Those are
technical hurdles that others would have to overcome if they adopt
that aggressive early approach.
However, certainly these smaller children are also physiologi-
cally different. There are immunologic risk factors, there are nutri-
tion factors, they are much more prone to other complications,
cerebral bleeds, that sort of thing, and so there are differences.
There is just one thing about this weight that I find fascinating.
I have done subanalyses looking at the normal-birth-weight range,
and even within the normal-birth-weight range, birth weight is
a very strong determinant of risk, which is a very curious and in-
teresting fact.
Dr Reddy. I think this is very important information to have
available. However, I personally think that the patient should be in-
dividualized, not necessarily bunched into 1 of 2 categories, early
and late or left-sided versus right-sided lesions. If the patients are
dependent on a ventilator or requiring prolonged prostaglandins in
the infusions, then wewould generally tend to intervene. However,
if the patient can be extubated and can be fed normally or can be
taken off prostaglandin, I think the operation can certainly be
delayed.
Dr Hickey.Wewould agree with you. We do not think our data
can strongly advocate for one approach or the other, so we agree
that the approach needs to be individualized. We also will inter-
vene very early on very small patients with truncus or coarctation
if we think that that child clinically is of acceptable risk to undergo
an operation early. However, we are also reassured that if we
choose to take a delayed approach, we are not taking on an exces-
sive morbidity risk.
Dr Reddy. I also think more recent data suggest that the gesta-
tional age may have an impact on the neurologic injury and the
brain maturation. That might be a more common factor for us to
delay surgery in these patients, if we can safely.
DrHickey.Certainly. Dr Gaynor’s group has done a lot of work
showing very nicely that babies born at term with certain lesions
are developmentally very immature, and that is a strong determi-
nant of neurologic injury. Therefore, although we have focused
on survival as the end point, we have not taken into account the
morbidity burden in the long-term with either strategy, and that
may be just as important.
DrReddy.One last question. Do you have any plans to do a pro-
spective study in this regard?
Dr Hickey. I think the numbers that we have generated, 80 over
10 years from 1600 patients, really preclude that.
Dr Frank A. Pigula (Boston, Mass).My question is whether it
is really fair to equate weight gain with growth in children who are
receiving prostaglandins and are intubated with various means of
nutritional support. I am not sure that they are really the same thing
in those patients.
My other comment is that in analysis of our unit with these pa-
tients, their gestational age has been more important than their
size. We can operate on very small patients, but we cannot make
them older when we operate on them. Could you please address
the age versus size issue?
Dr Hickey. When we pitched prematurity, that is, gestational
age to birth weight, consistently birth weight was the more reliable
determinant. That is because prematurity, although very important,rdiovascular Surgery c Volume 143, Number 1 135
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Das our data showed, is important because of the whole host of prob-
lems that come with it—certain lesions, certain other comorbid-
ities, certain genetic syndromes, and such like. That’s what the
data were telling us was accounting for the risk of prematurity.
Birth weight per se is a more reliable determinant as an indepen-
dent risk factor for death.
Dr Pigula. That is interesting. That is a little bit counter to what
we have seen in our group.
Dr Christian Pizarro (Wilmington, Del). That was a beautiful
job. I am unclear about how patients were fed and how the choice
was made. I saw you encountered a lot of gastrointestinal compli-
cations. A common problem we all face is that we see a tiny little
baby and want to use enteral feeds, but we are hesitant, particularly
in someone who has a shunt at the arterial level, such as an infant136 The Journal of Thoracic and Cardiovascular Surgwith truncus or hypoplastic left heart syndrome. What was the
choice regarding feeding or nutrition in those patients, and could
that be in any way related to the speed of weight gain?
DrHickey.That is entirely possible. I do not have all the data on
the mechanisms of which patients were fed. Certainly gastrointes-
tinal complications were common, as you expect in these very
small children. We try to feed them enterally if at all possible to
avoid necrotizing enterocolitis and other complications, but I do
not have the specifics of that information.
In terms of weight gain, I am not sure what actually gave rise to
the differences that we saw in weight gain. However, the category
that really stuck out was patients with coarctation. They are not
normally the infants who have all the other comorbidities, and
yet their weight gain was very poor to a high level of significance.ery c January 2012
FIGURE E1. Overview of the study cohort. CV, Cardiovascular; CHD,
congenital heart disease.
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